http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9415605-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07707223721223ce27dfca225f7d9c30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-20 |
| filingDate | 1994-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1574904939f4609146deaaff40c82ffd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cbb21651c9dd735ca9455e1172e7989 |
| publicationDate | 1994-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9415605-A1 |
| titleOfInvention | Acetal or ketal substituted therapeutic compounds |
| abstract | Acetal- and ketal-substituted compounds and pharmaceutical compositions thereof have the following formula: CORE MOIETY-(R)j, including resolved enantiomers and/or diastereomers, hydrates, salts, solvates and mixtures thereof. j is an integer from one to three, the core moiety is non-cyclic or cyclic and R may be selected from among hydrogen, halogen, hydroxyl, amino, substituted or unsubstituted alkyl C(1-6), alkenyl C(2-6), cyclic or heterocyclic groups, and groups having a structure prescribed by formula (I). At least one R has the formula (I): -(CH2)n-C-(R1)3, wherein n is an integer from three to twenty; R1 is selected from among hydrogen; halogen; hydroxide; substituted or unsubstituted C(1-6) alkyl, C(1-6) ether, C(2-6) alkenyl, cyclic or heterocyclic group; -OR2, R2 being hydrogen or a substituted or unsubstituted C(1-6) alkyl, C(2-6) alkenyl, cyclic or heterocyclic group; -(CH2)p-C(R3)3 (wherein p is zero or an integer from one to ten, R3 is hydrogen, halogen, hydroxide, substituted or unsubstituted C(1-6) alkyl, C(1-6) ether, C(2-6) alkenyl, cyclic or heterocyclic group, or -OR2, R2 being defined above). The inventive compounds are useful in a large variety of therapeutic indications for treating or preventing disease mediated by intracellular signaling through specific intracellular signaling pathways. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0193841-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0193841-A3 |
| priorityDate | 1993-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 536.